Global Forum

Meryl Comer speaks at the 2013 Global Forum: “Our mission is early AD diagnosis, which further defines our role as a catalyst funder for open source ‘Global NeuroDiscovery’ challenges that aim to advance innovation in self- administered mobile applications for brain health, Alzheimer’s clinical trial data mining for sex- based differences, and validation studies of mobile digital devices for assessing and tracking early cognitive decline.”

Read Meryl’s full remarks.